Hiroko Matsui
Impact in
- Drug Discovery top 10%
- Molecular Biology top 10%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Congenital heart defects research
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- RNA modifications and cancer
Papers in
-
- Congenital heart defects research 8
- Genomics and Phylogenetic Studies 4
- CRISPR and Genetic Engineering 4
- Genetics 16
- Genomics and Rare Diseases 6
- Co-authors
- Kelly A. Frazer (22 shared papers)Yumiko Nishimura (9 shared papers)Erin N. Smith (11 shared papers)Agnieszka D’Antonio‐Chronowska (11 shared papers)Matteo D’Antonio (11 shared papers)Yasuo Oyama (10 shared papers)Tomohiro M. Oyama (8 shared papers)David Jakubosky (8 shared papers)
- Journals
- Toxicology (4 papers)Nature Communications (3 papers)Toxicology in Vitro (3 papers)Stem Cell Reports (3 papers)Stem Cell Research (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroko Matsui
51 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 119
- Drug Discovery 2
- Molecular Biology 813
- Genetics 273
- Cancer Research 110
- Nutrition and Dietetics 109
Countries citing papers authored by Hiroko Matsui
This map shows the geographic impact of Hiroko Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Matsui more than expected).
Fields of papers citing papers by Hiroko Matsui
This network shows the impact of papers produced by Hiroko Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Matsui. The network helps show where Hiroko Matsui may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Matsui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 97 | |
| 2 | 2007 | 97 | |
| 3 | 2008 | 84 | |
| 4 | 2014 | 84 | |
| 5 | 2019 | 77 | |
| 6 | 2004 | 64 | |
| 7 | 2015 | 63 | |
| 8 | 2020 | 57 | |
| 9 | 2017 | 55 | |
| 10 | 2018 | 54 | |
| 11 | 2010 | 52 | |
| 12 | 2008 | 48 | |
| 13 | 2009 | 32 | |
| 14 | 2019 | 30 | |
| 15 | 2019 | 30 | |
| 16 | 2019 | 28 | |
| 17 | 2005 | 28 | |
| 18 | 2019 | 28 | |
| 19 | 2016 | 27 | |
| 20 | 2009 | 25 |
About Hiroko Matsui
Hiroko Matsui is a scholar working on Molecular Biology, Genetics, Epidemiology, Nutrition and Dietetics and Surgery, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Congenital heart defects research (8 papers), Genomics and Rare Diseases (6 papers), Trace Elements in Health (5 papers), Acute Myeloid Leukemia Research (4 papers), Genomics and Phylogenetic Studies (4 papers), Tissue Engineering and Regenerative Medicine (4 papers), Liver physiology and pathology (4 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Drug Discovery (2 citations), Molecular Biology (813 citations), Genetics (273 citations), Cancer Research (110 citations) and Nutrition and Dietetics (109 citations). Hiroko Matsui has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kelly A. Frazer, Yumiko Nishimura, Erin N. Smith, Agnieszka D’Antonio‐Chronowska, Matteo D’Antonio, Yasuo Oyama, Tomohiro M. Oyama, David Jakubosky, Toshihisa B. Oyama and Kristen Jepsen. Their work appears in journals such as Toxicology, Nature Communications, Toxicology in Vitro, Stem Cell Reports and Stem Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.